Table 1.
Groups/Contractions | TTI, g/s | SE, g/s |
---|---|---|
Protocol 1 (P = 0.245, n = 5) | ||
Control | 25,598 | 2,949 |
Saline | 32,092 | 3,280 |
DAMGO, 2 μg | 29,735 | 1,187 |
Protocol 2 (P = 0.489, n = 6) | ||
Control | 22,009 | 4,450 |
Saline | 26,005 | 3,347 |
TLQ, 1 μg | 23,980 | 3,798 |
TLQ + DAMGO | 25,445 | 4,825 |
Protocol 3 (P = 0.893, n = 7) | ||
Control | 19,444 | 2,781 |
Saline | 19,494 | 1,919 |
TLQ, 10 μg | 21,528 | 2,726 |
TLQ + DAMGO | 20,667 | 2,342 |
Protocol 4 (P = 0.114, n = 7) | ||
Control | 33,128 | 5,239 |
Saline | 30,824 | 3,725 |
GVIA,* 1 μg | 25,628 | 3,193 |
Protocol 5 (P = 0.07, n = 4) | ||
Control | 22,924 | 1,951 |
Saline | 32,283 | 2,750 |
30 min | 24,933 | 3,019 |
60 min | 32,878 | 3,047 |
90 min | 31,173 | 3,853 |
120 min | 29,275 | 2,593 |
Comparison of tension-time indexes within protocols. A one-way repeated-measures ANOVA revealed no differences between treatments. DAMGO, [d-Ala2,N-MePhe4,Gly-ol]-enkephalin; GVIA, ω-conotoxin-GVIA; TLQ, tertiapin-LQ; TTI, tension-time index.
Measurement recorded at time of maximal inhibition and combined for analysis.